About Vascular Biology and Hypertension Program, University of Alabama at Birmingham
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Vascular Biology and Hypertension Program, University of Alabama at Birmingham
During the past decade, Vascular Biology and Hypertension Program, University of Alabama at Birmingham conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Vascular Biology and Hypertension Program, University of Alabama at Birmingham"
#1 collaborator was "ABX CRO" with 1 trials as a collaborator, "AG Mednet Inc." with 1 trials as a collaborator, "Advanced Clinical, LLC" with 1 trials as a collaborator, "H2O Clinical LLC" with 1 trials as a collaborator and "ICON CEAC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Vascular Biology and Hypertension Program, University of Alabama at Birmingham
According to Clinical.Site data, the most researched conditions in "Vascular Biology and Hypertension Program, University of Alabama at Birmingham" are
"Coronary Artery Disease (CAD)" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Vascular Biology and Hypertension Program, University of Alabama at Birmingham" in a lesser frequency.
Clinical Trials Intervention Types at Vascular Biology and Hypertension Program, University of Alabama at Birmingham
Most popular intervention types in "Vascular Biology and Hypertension Program, University of Alabama at Birmingham" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Implantable Cardioverter Defibrillator" (1 trials), "Iobenguane I -123 Injection" (1 trials), "PET MPI" (1 trials), "Pharmacological stress agents" (1 trials) and "SPECT MPI" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Vascular Biology and Hypertension Program, University of Alabama at Birmingham
The vast majority of trials in "Vascular Biology and Hypertension Program, University of Alabama at Birmingham" are
2 trials for "All" genders.
Clinical Trials Status at Vascular Biology and Hypertension Program, University of Alabama at Birmingham
Currently, there are NaN active trials in "Vascular Biology and Hypertension Program, University of Alabama at Birmingham".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Vascular Biology and Hypertension Program, University of Alabama at Birmingham,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Vascular Biology and Hypertension Program, University of Alabama at Birmingham, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".